ArticleScientific reports2025
Application of image guided analyses to monitor fecal microbial composition and diversity in a human cohort.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The critical role of gut microbiota in human health and disease has been increasingly illustrated over the past decades, with a significant amount of research demonstrating an unmet need for self-monitor of the fecal microbial composition in an easily-accessible, rapid-time manner. In this study, we employed a tool for Smartphone Microbiome Evaluation and Analysis in Rapid-time (SMEAR) that uses images of fecal smears to predict microbial compositional characteristics in a human cohort. A subset of human fecal samples was randomly retrieved from the second wave of data collection in the Healthy Life in an Urban Setting (HELIUS) study cohort. Per sample, 16S rRNA gene sequencing data was generated in addition to an image of a fecal smear, spread on a standard A4 paper. Metagenomics-paired pictures were used to validate a computer vision-based technology to classify whether the sample is of low or high relative abundance of the 50 most abundant genera, and α-diversity (Shannon-index). In total, 888 fecal samples were used as an application of the SMEAR technology. SMEAR gave accurate predictions whether a fecal sample is of low or high relative abundance of Sporobacter, Oscillibacter and Intestinimonas (very good performance, AUC > 0.8, p-value < 0.001, for all models), as well as Neglecta, Megasphaera, Lachnospira, Methanobrevibacter, Harryflintia, Roseburia, and Dialister (good performance, AUC > 0.75, p-value < 0.001, for all models). Likewise, SMEAR could classify whether a fecal sample was of low or high α-diversity (AUC = 0.83, p-value < 0.001). Our study demonstrates that SMEAR robustly predicts microbial composition and diversity from digital images of fecal smears in a human cohort. These findings establish SMEAR as a new benchmark for rapid, cost-effective microbiome diagnostics and pave the way for its direct application in research settings and clinical validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.